Quantcast

Zoloft Lawsuits: Bernstein Liebhard LLP Notes More than 300 Claims Now Pending in Federal Zoloft Birth Defects Litigation

April 6, 2013

The Firm is currently investigating Zoloft lawsuits on behalf of victims of alleged Zoloft birth defects.

New York, NY (PRWEB) April 06, 2013

Bernstein Liebhard LLP notes that at least 330 Zoloft lawsuits are now pending in the federal multidistrict litigation established in U.S. District Court, Eastern District of Pennsylvania, for claims involving Zoloft birth defect allegations. On April 1st, the Court published two new Pretrial Orders on the Zoloft litigation´s website, one of which amends the previously established Joint Discovery and Scheduling Plan. The second Order posted by the Court governs the process for selection of the litigation´s Initial Discovery Group. (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation – MDL 2342)

“We have heard from numerous families whose children may have been victims of Zoloft birth defects. We are not surprised that the number of Zoloft lawsuit filings has already surpassed 300,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Zoloft lawsuit consultations to victims of birth defects allegedly associated with the drug.

Zoloft Birth Defects

Zoloft belongs to a class of drugs known as selective serotonin reuptake inhibitor (SSRI) antidepressants, and is used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. In November 2006, the U.S. Food & Drug Administration (FDA) added warnings about a potential risk of persistent pulmonary hypertension in newborns (PPHN) from Zoloft and other SSRI antidepressants when taken after the 20th week of pregnancy.* A second study published in the British Medical Journal in September 2009 found that SSRI antidepressants like Zoloft increase the risk of heart defects when taken during the first trimester.**

Court documents indicate that the first trials in the federal Zoloft birth defect litigation will begin in October 2014. All of the Zoloft lawsuits pending in the Eastern District of Pennsylvania allege that use of Zoloft during pregnancy can increase the risk of delivering a child with severe birth defects, including pulmonary hypertension in newborns (PPHN), spina bifida and other neural tube defects, heart defects, abdominal defects, and club foot.

Victims of possible Zoloft birth defects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about Zoloft lawsuits, please visit Bernstein Liebhard LLP´s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today by calling (877) 779-1414.

*fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126522.htm

** bmj.com/content/339/bmj.b3569

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info(at)consumerinjurylawyers(dot)com

http://www.consumerinjurylawyers.com

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebzoloft-lawsuits/zoloft-birth-defects/prweb10606628.htm


Source: prweb



comments powered by Disqus